Gelclair: managing the symptoms of oral mucositis.
Oral mucositis is a common side-effect of oncology therapies and other diseases. This article gives an overview of the issues associated with oral mucositis, and an outline of a new product, Gelclair, that may address some of these issues.
Smith
T
T
D000970:Antineoplastic Agents / Q000009:adverse effects; D004338:Drug Combinations; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use*; D009061:Mouth Mucosa / Q000528:radiation effects; D010592:Pharmaceutic Aids / Q000627:therapeutic use*; D011205:Povidone / Q000627:therapeutic use*; D011832:Radiation Injuries / Q000209:etiology; D013280:Stomatitis / Q000188:drug therapy* / Q000209:etiology
D000970:Antineoplastic Agents; D004338:Drug Combinations; C439265:Gelclair; D010592:Pharmaceutic Aids; D006820:Hyaluronic Acid; D011205:Povidone